A new report from the Government Accountability Office (GAO) is drawing attention to the structure of the vision and dental insurance markets in the United States and raising important questions about competition, transparency, and patient choice.
The report examines how much of the market is controlled by a small number of insurers and how some companies operate across multiple parts of the vision care system. These trends are important because when a small number of companies control large portions of a market, it can influence how care is delivered and how patients access services.
The GAO found that vision insurance markets vary widely from state to state, but in many places just a few insurers control a large share of coverage.
In the group vision insurance market, the three largest insurers in each state control between about 41 percent and 96 percent of enrollment, with a median market share of roughly 77 percent.
In the individual vision insurance market, the three largest insurers control between about 56 percent and nearly 99 percent of enrollment, with a median market share of about 78 percent.
These figures do not automatically mean patients are harmed, but they do raise reasonable questions about how much competition exists in the market and whether patients, employers, and providers have enough meaningful choice.
The report also notes that some companies involved in vision insurance participate in multiple parts of the vision care system. In some cases, companies may offer insurance coverage while also operating retail optical brands, manufacturing lenses and frames, or owning optical laboratories that produce prescription eyewear.
When companies operate across multiple parts of the system, it can create efficiencies. But it can also raise concerns about whether incentives are aligned with what is best for patients and providers.
For example, stakeholders interviewed during the review raised questions about whether provider contracts, reimbursement structures, or product choices may sometimes be influenced by business relationships within the system.
For patients, the structure of the vision insurance market can affect several aspects of care, including where they receive services, what products are available, and how much they pay out of pocket.
When markets are dominated by a small number of companies, patients may experience fewer choices, less transparency, and more complexity when trying to understand how their coverage works.
For independent providers, these market dynamics may affect contract negotiations, reimbursement levels, and the ability to make care decisions based primarily on patient needs.
Vision care plays an important role in overall health. Eye exams help detect chronic conditions such as diabetes and hypertension, support children’s learning and development, and help older adults maintain independence.
Ensuring that vision coverage supports access to high-quality care is an important part of maintaining a healthcare system that works for patients and families.
The GAO report does not offer specific policy recommendations, but it provides valuable data that policymakers, employers, providers, and patients can use to better understand how the vision insurance market operates.
As lawmakers continue examining issues related to transparency and competition in healthcare markets, the goal should remain clear: ensuring that patients have access to care, providers can practice independently, and the system remains focused on delivering high-quality healthcare.
The bipartisan DOC Access Act is key legislation being discussed as policymakers consider ways to improve transparency and fairness in vision and dental benefit plans.